Home > PJ (Current issue) > Meetings | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7361 p170
6 August 2005

This article
Reprint   Photocopy

PDF 90K, Acrobat Reader

Meetings

See Reports

Standing Advisory Committee on Antimicrobial Resistance (SACAR)

Gareth Jones, editor of Hospital Pharmacist, reports from a meeting held to promote the rational use of antimicrobials in acute hospitals

“Resistance is futile”, a conference organised by the Specialist Advisory Committee on Antimicrobial Resistance and National Prescribing Centre to promote the rational use of antimicrobials in acute hospitals, took place at the Royal Pharmaceutical Society on 12 July.

Antimicrobial posts may disappear

Hayley Wickens

Hayley Wickens: need evidence base

One-third of specialist antimicrobial pharmacy posts may disappear when funding from the Department of Health for the clinical pharmacy initiative ends next year, according to Hayley Wickens, senior microbiology pharmacist, St Mary’s Hospital, London. The DoH announced in June 2003 that £12m was to be provided over three years to promote the prudent use of antibiotics in acute trusts in England. Dr Wickens sent questionnaires to 183 acute hospitals in April 2005 to find out what procedures were being implemented to promote rational antimicrobial use. She presented results of a preliminary analysis from the first 64 forms to be returned.

Over 90 per cent of trusts now have a specialist member of staff dealing with antibiotic prescribing. Almost half of these are D grade pharmacists, with E and C grade pharmacists, respectively, being the next largest groups. The majority of posts are being funded under hospital pharmacy initiative money. However, many posts are permanent despite being funded by DoH money, and Dr Wickens suggested that trusts have put together business cases to use the money while it is available, and then continue the funding afterwards.

The responsibilities of antimicrobial pharmacists include monitoring antibiotic use, writing evidence-based guidelines, education and clinical work. Production of expenditure reports has almost doubled as a result of the initiative. Reporting of defined daily doses (the preferred method for reporting antibiotic use) has increased from less than 5 per cent to over 30 per cent and prevalence studies are now performed in over 60 per cent of trusts. More than 80 per cent of trusts now have a formulary and guidelines and twice as many trusts now have an intravenous-to-oral switching policy.

“We need to build an evidence base for our activities,” said Dr Wickens, explaining that it will otherwise be difficult to justify any pharmacist role. She also highlighted the challenge of finding funding to ensure that the one-third of posts that are not permanent are able to continue next year.

Guidelines are variable

Variation in clinical practice is a sign that guidelines are required, said Richard Mayon-White, department of primary health care, University of Oxford. Antimicrobial prescribing guidelines provide a better chance that an effective treatment will be chosen and reduce inequality in the provision of health care. They also force prescribers to gather and use better information, which leads to clarity of decisions and facilitates audit. There are, however, risks with guidelines because evidence can be wrong or inadequate and the advice can be inflexible, he suggested.

A literature review in 1999 found 11 papers that demonstrated a reduction in antibiotic resistance could be achieved with guidelines. The National Audit Office has cited three case studies where Clostridium difficile was controlled by antibiotic policies. The NAO also found that 90 per cent of English hospitals had antimicrobial guidelines in 1999. More recent surveys suggest that this figure may have increased to around 95 per cent.

A survey of 23 antimicrobial guidelines in the south east of England found that policies range in size from two to 61 pages of A4, although four had pocket-size summaries. Three hospitals published their policy on their intranet and one used a laminated notice. “Thought is given to how to disseminate the policies,” said Dr Mayon-White, adding, “[so] they do not just sit on the shelf.” They are typically one year old and are revised in a two-year cycle. Other strengths of these guidelines included ingenuity in design, increasing use of electronic versions, collaborations with community and neighbouring hospitals and a good coverage of respiratory and urinary infections. Weaknesses included that a few were out of date, thin on evidence, too large to carry around and had variable content.

Dr Mayon-White commended a template for hospital antimicrobial guidelines written by the Specialist Advisory Committee on Antimicrobial Resistance (SACAR). This template was published in the July/August issue of Hospital Pharmacist (2005;12:280).

With regard to national antimicrobial guidelines, Dr Mayon-White said that some people opposed them, suggesting that “their organisms are different so policies should be determined by local experience”. He said that this does not seem to reflect reality.. He asked participants if they would welcome a national co-ordinated evidence base for antimicrobial prescribing. If this were to happen, there would be a literature search and first draft produced. This would be sent to SACAR members and other interested parties for consultation, leading to a consensus of the evidence base.

A team game

Prescribing is a team game, according to Peter Davey, professor in pharmacoeconomics, University of Dundee. He said that there had been a big shift in medical education to recognise that prescribing is not just about pharmacology and pharmaceuticals, but also attitudes, behaviour and team working. “In the past we thought about prescribing as someone writing a prescription, [but today] it is all about identifying who needs the drug, correctly prescribing, dispensing and administering it, and monitoring the outcome,” he said. He commented that whether the prescribing is independent or supplementary, there needs to be a team looking at medicines and the patient journey. “We need to establish the competencies and decide who will do what,” he said.

Professor Davey said that health care had much to learn from the airline industry. Research had shown that most crashes occurred as a result of a failure of human interaction and communication, rather than a technical problem. Another problem was that teams are often brought together for just one shift, which also occurs in health care. Training in aviation had also focused just on flight simulators, but now also covers interactions with other members of the crew. One of the important skills, which is now being taught to surgeons, is situation awareness. This is the ability to gather and understand information and then anticipate future problems and communicate these to colleagues. Other skills being taught include decision-making, task management, leadership and communication.

Pharmacists focus more on drug issues than microbiological or clinical outcomes, suggested Professor Davey, citing a systematic review of published literature on interventions for patients receiving antibiotics. Interventions by antimicrobial teams were more balanced, affecting microbiological and clinical outcome to a greater degree. “In prescribing antimicrobials, we need a team that has microbiology, clinical and pharmacy input,” said Professor Davey.


©The Pharmaceutical Journal